Inmed Pharmaceuticals Inc. [IMLFF]

Source: 

Company Overview

We are a clinical stagepharmaceutical company developing a pipeline of prescription-based products, including rare cannabinoids and novel cannabinoid analogs,targeting the treatment of diseases with high unmet medical needs (“Product Candidates”). Together with our subsidiary BayMedica,LLC, we also have significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors(“Products”). We are developing multiple manufacturing approaches for synthesizing rare cannabinoids for potential use inpharmaceutical Product Candidates and Products. Our know-how includes traditional approaches such as chemical synthesis and biosynthesis,as well as a proprietary, integrated manufacturing approach called IntegraSynTM. We are dedicated to delivering new therapeuticalternatives to patients and consumers who may benefit from cannabinoid-based products.